KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | -17.2% | 55,700 | -27.8% | 0.00% | – |
| Q4 2021 | $93,000 | -58.7% | 77,100 | -10.2% | 0.00% | – |
| Q3 2021 | $225,000 | -50.5% | 85,900 | 0.0% | 0.00% | – |
| Q2 2021 | $455,000 | +59.1% | 85,900 | +102.1% | 0.00% | – |
| Q1 2021 | $286,000 | -29.2% | 42,500 | -28.7% | 0.00% | – |
| Q4 2020 | $404,000 | -8.2% | 59,600 | +1.5% | 0.00% | – |
| Q3 2020 | $440,000 | -28.7% | 58,700 | 0.0% | 0.00% | – |
| Q2 2020 | $617,000 | +61.9% | 58,700 | +35.3% | 0.00% | – |
| Q1 2020 | $381,000 | +556.9% | 43,400 | +176.4% | 0.00% | – |
| Q4 2019 | $58,000 | -3.3% | 15,700 | 0.0% | 0.00% | – |
| Q3 2019 | $60,000 | -40.0% | 15,700 | 0.0% | 0.00% | – |
| Q2 2019 | $100,000 | -78.1% | 15,700 | -21.5% | 0.00% | – |
| Q3 2017 | $457,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |